The Capitol LedgerEvery move in Congress, on the record
HomeBillsRecordsLedger AI

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

AboutFAQFeedbackTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

The Capitol Ledger

Built from the Congressional Record and Congress.gov. Every summary links to its source.

The projectAboutFAQFeedback
LegalTerms of ServicePrivacy Policy
Follow us onlineInstagram

Summaries are AI-generated from primary sources. Verify anything important against the original record.

All bills
H.R. 7184·119th Congress·Introduced Jan 21, 2026

PRESS Act

IntroducedCrime and Law EnforcementSubstantive
View bill text
Sponsor
Rep. McDowell, Addison P. [R-NC-6]
Committees
Judiciary Committee (primary)
Last action
Jul 15, 2026

Bottom line

The PRESS Act expands federal law enforcement's ability to prosecute individuals involved in the production and distribution of illicit drug manufacturing equipment outside U.S. borders, aiming to curb the flow of counterfeit controlled substances into the country.

What it actually does

This bill, known as the PRESS Act, amends the Controlled Substances Act to establish extraterritorial jurisdiction over the manufacture and distribution of pill press machines, encapsulating machines, and related materials. It makes it unlawful for any person to produce or distribute such equipment if they intend or know it will be used to manufacture controlled substances or listed chemicals that will be unlawfully imported into the United States. The bill also establishes new criminal penalties for these offenses and directs the U.S. Sentencing Commission to update sentencing guidelines.

Proponents argue

Supporters argue that this bill is a critical step in combating the opioid crisis and the proliferation of illicit drugs like fentanyl. They contend that by targeting the upstream supply chain of drug manufacturing equipment, the U.S. can disrupt the production of counterfeit pills before they reach American communities. This proactive approach is seen as essential to protect public health and safety from dangerous synthetic substances.

Opponents contend

Critics might argue that while the intent is laudable, expanding extraterritorial jurisdiction could lead to complex international legal challenges and potential diplomatic tensions. Some may also raise concerns about the practical enforceability of such broad jurisdiction, suggesting that it might be difficult to prove intent or knowledge regarding unlawful importation, potentially leading to overreach or ineffective prosecutions.

The bill is concise and clearly written, making it accessible for a reader to understand its core provisions within a short timeframe.

Section 2(a), amending 21 U.S.C. 959

Establishing Unlawful Acts for Manufacturing/Distributing Illicit Drug Equipment Abroad

prominently featuredstraightforward

This provision makes it illegal for anyone, anywhere in the world, to manufacture or distribute equipment like pill presses, encapsulating machines, or even gelatin capsules, if they know or intend for that equipment to be used to make illegal drugs or chemicals, and they also know or have reason to believe those drugs will be smuggled into the United States. This extends U.S. law enforcement reach beyond its borders to target the source of illicit drug manufacturing tools.

GroupImpactMechanismScale
GroupManufacturers and distributors of pill press machines and related equipment globallyImpactIncreased legal risk and potential criminal prosecution under U.S. lawMechanismDirect amendment to the Controlled Substances Act, expanding prohibited acts and jurisdictionScaleGlobal, targeting individuals and entities involved in the illicit drug supply chain
GroupDrug traffickers and criminal organizationsImpactDisruption of supply chains for illicit drug manufacturing equipment, potentially increasing costs and difficulty in producing counterfeit substancesMechanismCriminalization of the upstream supply of manufacturing toolsScaleSignificant, aiming to reduce the availability of tools for large-scale illicit drug production
GroupU.S. law enforcement agencies (DEA, DOJ)ImpactExpanded authority and tools to combat international drug traffickingMechanismNew legal grounds for investigation and prosecutionScaleEnhanced operational capabilities

Supporters argue

Supporters argue this provision is crucial for tackling the root causes of the opioid epidemic by targeting the foreign entities that supply the tools for illicit drug production. They believe it will significantly disrupt the flow of counterfeit pills, especially those containing fentanyl, into the United States, thereby saving lives.

Critics contend

Critics might contend that while the goal is laudable, enforcing such broad extraterritorial jurisdiction could be challenging and might strain international relations. They may argue that proving intent or knowledge across borders is difficult, potentially leading to limited successful prosecutions or unintended diplomatic consequences.

Tradeoffs

The provision balances the desire to aggressively combat international drug trafficking with the complexities of enforcing U.S. law in foreign jurisdictions and potential impacts on international relations.

Section 2(b), amending 21 U.S.C. 960

Enhanced Criminal Penalties for Illicit Pill Press Activities

prominently featuredstraightforward

This section establishes specific criminal penalties for violating the new prohibition on manufacturing or distributing illicit pill press equipment. It sets a maximum imprisonment period of 8 years for general violations, which can increase to 15 years if the offense involves a large quantity (over 1,000 kilograms of chemical/product or more than 100 machines). This aims to deter individuals and organizations from engaging in these activities by imposing significant legal consequences.

About this analysis. AI-Generated from the official bill text and available committee reports. Gaps in available data are noted explicitly. Verify important details with the official Congress.gov record.

On this page

  • Executive summary
  • Key provisions
  • Follow the money
  • Critical analysis
  • Questions to ask
Ask Ledger AI about this